These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22657157)

  • 41. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
    Foeldvari I; Wierk A
    J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features of childhood localized scleroderma in an incidence cohort.
    Herrick AL; Ennis H; Bhushan M; Silman AJ; Baildam EM
    Rheumatology (Oxford); 2011 Oct; 50(10):1865-8. PubMed ID: 21729934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.
    Goodkin DE; Rudick RA; VanderBrug Medendorp S; Greene T; Schwetz KM; Fischer J; Daughtry MM; Ross J; Van Dyke C
    Online J Curr Clin Trials; 1992 Sep; Doc No 19():[7723 words; 89 paragraphs]. PubMed ID: 1343611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term follow-up of renal function after high-dose methotrexate treatment in children.
    Grönroos MH; Jahnukainen T; Möttönen M; Perkkiö M; Irjala K; Salmi TT
    Pediatr Blood Cancer; 2008 Oct; 51(4):535-9. PubMed ID: 18523995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis?
    Akbulut S; Arikanoglu Z; Senol A; Sogutcu N; Basbug M; Yeniaras E; Yagmur Y
    Arch Gynecol Obstet; 2011 Nov; 284(5):1189-95. PubMed ID: 21207047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register.
    Lie E; van der Heijde D; Uhlig T; Mikkelsen K; Kalstad S; Kaufmann C; Rødevand E; Kvien TK
    Ann Rheum Dis; 2011 Dec; 70(12):2103-10. PubMed ID: 21875874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
    Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
    Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
    Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
    Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging.
    Weibel L; Theiler M; Howell KJ; Denton CP; Waelchli R; Atherton D; Woo P; Harper JI
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1609-1616. PubMed ID: 32080907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.
    Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F
    Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.